Patent details

Basic Information

Publication number:

EP3469907

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP181925934

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS

French Title of Invention:

COMPOSÉS PYRIDINONE-PYRIDINYL SUBSTITUÉS

German Title of Invention:

SUBSTITUIERTE PYRIDINON-PYRIDINYL-VERBINDUNGEN

SPC Number:

Dates

Filing date:

06/12/2011

Grant date:

03/03/2021

EP Publication Date:

17/04/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/03/2021

EP B1 Publication Date:

03/03/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

06/12/2021

Expiration date:

06/12/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

24/02/2021

 

 

Name:

Aclaris Therapeutics, Inc.

Address:

640 Lee Road Suite 200, Wayne, Pennsylvania 19087, United States (US)

Inventor

1

Name:

DEVADAS, Belekudru

Address:

United States (US)

2

Name:

MONAHAN, Joseph B.

Address:

United States (US)

3

Name:

SELNESS, Shaun R.

Address:

United States (US)

4

Name:

SCHINDLER, John F.

Address:

United States (US)

Priority

Priority Number:

42007410 P

Priority Date:

06/12/2010

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/44; A61K 31/4412; A61K 31/506; A61P 3/10; A61P 29/00; A61P 35/00; A61P 37/00; C07D 409/14; C07D 413/14; C07D 417/14;

Publication

European Patent Bulletin

Issue number:

202109

Publication date:

03/03/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages